683 related articles for article (PubMed ID: 18404148)
21. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
22. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1.
Mimori K; Fukagawa T; Kosaka Y; Kita Y; Ishikawa K; Etoh T; Iinuma H; Sasako M; Mori M
Clin Cancer Res; 2008 May; 14(9):2609-16. PubMed ID: 18451223
[TBL] [Abstract][Full Text] [Related]
23. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
24. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
25. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
26. The polymerase chain reaction in the detection of micrometastases and circulating tumor cells: present status and future potential.
Ghossein RA; Rosai J
Anat Pathol; 1998; 3():233-51. PubMed ID: 10389588
[No Abstract] [Full Text] [Related]
27. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
[TBL] [Abstract][Full Text] [Related]
28. Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells.
Molloy TJ; Bosma AJ; van't Veer LJ
Breast Cancer Res Treat; 2008 Nov; 112(2):297-307. PubMed ID: 18213476
[TBL] [Abstract][Full Text] [Related]
29. Detection of circulating tumor cells in bladder cancer patients.
Nezos A; Pissimisis N; Lembessis P; Sourla A; Dimopoulos P; Dimopoulos T; Tzelepis K; Koutsilieris M
Cancer Treat Rev; 2009 May; 35(3):272-9. PubMed ID: 19103472
[TBL] [Abstract][Full Text] [Related]
30. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
31. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood.
Fong SM; Lee MK; Adusumilli PS; Kelly KJ
Surgery; 2009 Sep; 146(3):498-505. PubMed ID: 19715807
[TBL] [Abstract][Full Text] [Related]
34. Isolated tumor cells in the bone marrow: value of a new diagnostic method in the TNM-staging of solid tumors.
Werner M; Nasarek A; Georgii A
Gen Diagn Pathol; 1996 Jun; 142(1):1-6. PubMed ID: 8793480
[No Abstract] [Full Text] [Related]
35. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
36. Biology of metastatic disease.
Pass HI; Temeck BA
Chest Surg Clin N Am; 1998 Feb; 8(1):1-11. PubMed ID: 9515169
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumour cell detection on its way to routine diagnostic implementation?
Sleijfer S; Gratama JW; Sieuwerts AM; Kraan J; Martens JW; Foekens JA
Eur J Cancer; 2007 Dec; 43(18):2645-50. PubMed ID: 17977713
[TBL] [Abstract][Full Text] [Related]
38. Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res., 8: 2073-2084, 2002.
Fiegl M; Kircher B; Zojer N
Clin Cancer Res; 2003 Mar; 9(3):1224-5; author reply 1226. PubMed ID: 12631629
[No Abstract] [Full Text] [Related]
39. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
[TBL] [Abstract][Full Text] [Related]
40. Cancer diagnostics: one-stop shop.
Uhr JW
Nature; 2007 Dec; 450(7173):1168-9. PubMed ID: 18097389
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
